Return to Answers From the Lab

Membranous nephropathy assay: PMND1

By Samantha Rossi • August 16, 2022
Related Episodes
Alzheimer’s Disease and Testing Innovations: Bill Morice, M.D., Ph.D.

By Sarah Jarvis • April 25, 2024
Assay identifies patients eligible for new ovarian cancer drug: Maryam Shahi, M.D.

By Samantha Rossi • April 23, 2024
Lab Week and Noteworthy News: Bill Morice, M.D., Ph.D.

By Sarah Jarvis • April 18, 2024

Samantha Rossi

Samantha Rossi is a Digital Marketing Manager at Mayo Clinic Laboratories. She supports marketing strategies for product management and specialty testing. Samantha has worked at Mayo Clinic since 2019.

Related Posts
Mary Jo Williamson talks resiliency and agility on Fierce Healthcare podcast
Mayo Clinic Laboratory and Pathology Research Roundup: April 23
Assay identifies patients eligible for new ovarian cancer drug: Maryam Shahi, M.D.